Immunity for Health

IfH Symposium: Innovations in Antibody-Based Biologics

11 Jun 2026 | Landmark Building, UZ Brussels, Belgium

ExpertiseUpdated on 18 May 2026

Oligodendrocyte biology and remyelination platform

business developer BIOMED / academic liaison manager Health Campus Limburg DC at Hasselt University - Biomedical Research Institute

Diepenbeek, Belgium

About

Are you developing new therapies for neurodegenerative disease that target oligodendrocyte biology or de- and remyelination?

▶ Progress your development programs faster by building on our expertise glial cell biology, neuroscience, and lipid metabolism.

▶ Our validated models are continuously exploited in proprietary research programs and service activities for the private sector.

▶ We are keen on creating collaborative and longlasting partnerships by meeting rapidly changing needs and requirements in a flexible way and delivering on our promises.

POSSIBLE APPLICATIONS

• Test the therapeutic activity of candidate therapies on oligodendrocyte biology and remyelination in vitro at three levels: differentiation and proliferation of oligodendrocyte precursor cells (OPCs), migration behaviour of OPCs and axon-wrapping potential. Multiple conditions can be tested in parallel.

• Test the effect of therapies in a more complex multicellular brain environment using ex vivo in brain slice cultures. Multiple conditions can be tested in parallel.

• Test your candidate therapies in in vivo models which includes a battery of functional, structural, and clinical outcome measures.

Similar opportunities

  • Expertise

    Blood-Brain Barrier in vitro to in vivo models

    An Voets

    business developer BIOMED / academic liaison manager Health Campus Limburg DC at Hasselt University - Biomedical Research Institute

    Diepenbeek, Belgium

  • Expertise

    Controlled expression of sa-mRNA

    • Immunology
    • Immunotherapy
    • Clinical Trials
    • Preclinical trials
    • Vaccine Development

    Sven ARNOUTS

    Business Development Manager at Ghent University - provaxs

    Merelbeke, Belgium

  • Expertise

    Angiogenesis in vitro to in vivo toolbox

    An Voets

    business developer BIOMED / academic liaison manager Health Campus Limburg DC at Hasselt University - Biomedical Research Institute

    Diepenbeek, Belgium